Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ORIC Pharmaceuticals, Inc.
Market Cap
$1.21B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.21B
Operating Margin
11.12%
TTM Avg
18.27%
3Y Avg
-5.84%
5Y Avg
-26.54%
Market Cap
$1.22B
Operating Margin
6.39%
TTM Avg
1.60%
3Y Avg
-1.75%
5Y Avg
0.68%
Market Cap
$1.22B
Operating Margin
-11.96%
TTM Avg
-38.52%
3Y Avg
-75.67%
5Y Avg
-204.09%
Market Cap
$1.22B
Operating Margin
-0.15%
TTM Avg
-15.16%
3Y Avg
-41.30%
5Y Avg
-41.30%
Market Cap
$1.18B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.16B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.15B
Operating Margin
-240.38%
TTM Avg
-171.82%
3Y Avg
-189.28%
5Y Avg
-240.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.21B | 0.00% | 0.00% | 0.00% | 0.00% |
| MannKind Corporation (MNKD)vs › | $1.21B | 11.12% | 18.27% | -5.84% | -26.54% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 6.39% | 1.60% | -1.75% | 0.68% |
| Cronos Group Inc. (CRON)vs › | $1.22B | -11.96% | -38.52% | -75.67% | -204.09% |
| Omada Health (OMDA)vs › | $1.22B | -0.15% | -15.16% | -41.30% | -41.30% |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.18B | 0.00% | 0.00% | 0.00% | 0.00% |
| Kardigan, Inc. (KARD)vs › | $1.25B | 0.00% | 0.00% | 0.00% | 0.00% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.16B | 0.00% | 0.00% | 0.00% | 0.00% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -240.38% | -171.82% | -189.28% | -240.55% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 15.66% | 23.78% | 24.92% | 19.79% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
